Delivery Order SPE2DR25D2206-SPE2DR26F9BA5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,114.48 to AmerisourceBergen Drug Corp for SAMSCA 30 mg tablets (10-count units) under a firm fixed-price contract. The award was made on November 10, 2025, with an ultimate completion date of December 3, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $10,623.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) with an ultimate completion date of September 15, 2025. This non-set-aside competitive award was issued on August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SAMSCA 15 mg tablets (10 count) with a ceiling value of $10,623.60. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded a delivery order valued at $14,697.32 to AmerisourceBergen Drug Corp for the supply of SAMSCA 30 mg tablets (10-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside, competitively awarded contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $21,247.20 to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count packaging), with an ultimate completion date of October 16, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's headquarters...
- The Defense Logistics Agency awarded a $44,091.96 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of SAMSCA 30 mg tablets (10-count units). This firm fixed price delivery order, with an ultimate completion date of September 4, 2025, represents a non-competitive, non-set-aside award to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $21,247.20 to AmerisourceBergen Drug Corp for the supply of Samsca 15 mg tablets (10-count units) under a firm fixed-price contract. The award, made on September 17, 2025, with an ultimate completion date of October 8, 2025, represents a non-competitive delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $7,348.68 to AmerisourceBergen Drug Corp for the supply of Samsca 30 mg tablets (10-count) under a firm fixed price contract. The award was issued on July 31, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, non-set-aside contract represents a child delivery order executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is...
- The Defense Logistics Agency awarded a $11,022.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of SAMSCA 30 mg tablets (10-count units). This non-set-aside contract is scheduled for completion by June 17, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of SAMSCA 15 MG TABLET 10S. The $10,269.78 delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp as the sole prime contractor. This IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9BA5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,856.70 to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) on November 10, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving defense and veteran healthcare systems with a comprehensive portfolio of pharmaceutical products and medical supplies. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to military healthcare programs worldwide. The company's federal contract performance demonstrates consistent capability in meeting open competition requirements across multiple therapeutic domains through delivery orders employing firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 11/10/25 |